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ABSTRACT
The cell cycle genes homology region (CHR) has
been identified as a DNA element with an impor-
tant role in transcriptional regulation of late cell cy-
cle genes. It has been shown that such genes are
controlled by DREAM, MMB and FOXM1-MuvB and
that these protein complexes can contact DNA via
CHR sites. However, it has not been elucidated which
sequence variations of the canonical CHR are func-
tional and how frequent CHR-based regulation is uti-
lized in mammalian genomes. Here, we define the
spectrum of functional CHR elements. As the ba-
sis for a computational meta-analysis, we identify
new CHR sequences and compile phylogenetic mo-
tif conservation as well as genome-wide protein-
DNA binding and gene expression data. We identify
CHR elements in most late cell cycle genes bind-
ing DREAM, MMB, or FOXM1-MuvB. In contrast, Myb-
and forkhead-binding sites are underrepresented in
both early and late cell cycle genes. Our findings
support a general mechanism: sequential binding of
DREAM, MMB and FOXM1-MuvB complexes to late
cell cycle genes requires CHR elements. Taken to-
gether, we define the group of CHR-regulated genes
in mammalian genomes and provide evidence that
the CHR is the central promoter element in transcrip-
tional regulation of late cell cycle genes by DREAM,
MMB and FOXM1-MuvB.
INTRODUCTION
Genes expressed periodically during the cell cycle are often
regulated on the level of transcription. The cell cycle genes
homology region CHR is a central DNA element in many
promoters of late cell cycle genes with a maximal expres-
sion in G2 and M phases (1). The CHR primarily controls
transcriptional repression of these genes in G0 and early
G1. Moreover, we recently provided evidence that the CHR
is also required for full activation in late cell cycle phases
(2). The CHR is bound by LIN9, LIN37, LIN52, LIN54
and RBBP4 proteins, which form the MuvB core complex.
It has been suggested that LIN54 is the component which
mediates binding to the CHR (3). Depending on the cell
cycle phase, several other proteins interact with the MuvB
core. In G0 and early G1, the MuvB proteins bind E2F4,
DP1 and p130 forming the DREAM complex (4,5). This
protein complex represses gene activity when bound to pro-
moters of cell cycle genes (4). In some promoters, binding
of DREAM to the CHR is supported by an adjacent cell
cycle-dependent element (CDE), a motif rich in guanines
and cytosines and located upstream of the CHR and sep-
arated from it by a spacer of four nucleotides (2). When a
cell progresses through G1 to S phase, E2F4, DP1 and p130
proteins dissociate from MuvB and are replaced by B-MYB
forming the MMB (Myb-MuvB) complex. In late S phase,
MMB recruits FOXM1 to the promoters of late cell cy-
cle genes. Finally, proteasome-mediated degradation of B-
MYB results in maximal expression of these genes through
the FOXM1–MuvB complex in G2 and M phases (6–8).
In addition to CHR motifs, three other elements have
been implicated in recruiting MuvB-based protein com-
plexes, namely, E2F elements (binding E2F/DP dimers),
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MBS motifs (MYB-binding sites) and FBS (forkhead sites
binding FOXM1) (4,7–9). However, it appears that not all
interactions of these transcription factors with their canon-
ical recognition sites are required for the function of MuvB-
containing complexes. For instance, FOXM1 binding to
promoters of cell cycle genes does not require forkhead-
binding sites, but rather depends on CHR elements (6).
The diversity of known CHR sequences is small. To
date, four variants of the CHR motif have been described:
the most common, TTTGAA, was shown to be a cen-
tral promoter element in genes such as Ccnb2 (10), Cdk1
(11), Aurkb (12) and Cdca3 (Tome1) (13). The motifs TT-
TAAA and CTTGAA have been identified to be functional
CHRs in the Ccnb1 (14) and CCNA2 (11) promoters, re-
spectively. A CHR-like sequence was identified in the mouse
Mybl2 (B-Myb) promoter and named downstream repres-
sion site (DRS) (15–17). This motif (TAGGAA) is func-
tional in combination with an adjacent E2F site although
it differs in two nucleotides from the common TTTGAA
CHR sequence. Another example was established with the
TTCAAA sites of the Ube2c and Plk4 promoters, showing
that inverse CHR elements are also functional (2,18). Inter-
estingly, in Caenorhabditis elegans and Drosophila, the or-
thologous DREAM complexes also bind to CHR-like se-
quences (19,20).
In this study, we search for DREAM, MMB and
FOXM1-binding sites in human promoter regions in a
genome-wide screen. In our computational meta-analysis
based on genome-wide protein-DNA binding, gene expres-
sion data and analysis of phylogenetic motif conservation,
we identify CHR elements in most late cell cycle genes
bound by DREAM, MMB or FOXM1. In contrast, a large
number of the observed E2F motifs in DREAM-bound
promoters is found in early cell cycle genes. Furthermore,
Myb and forkhead-binding sites are underrepresented com-
pared to CHRs in cell cycle regulated genes bound by MMB
or FOXM1. Taken together, our findings suggest the CHR
as the central promoter element in transcriptional regula-
tion of late cell cycle genes. We propose that regulation of
these genes by a sequential binding of DREAM, MMB and
FOXM1-MuvB always requires a CHR promoter element.
MATERIALS AND METHODS
Cell culture
NIH3T3, HFF and F9 cells from DSMZ (Braunschweig,
Germany) were grown in DMEM supplemented with 10%
FCS and penicillin/streptomycin. Cells were synchronized
in G0 either by serum starvation (DMEM with 0% FCS) for
60 h or by density-arrest. For cell cycle analyses, NIH3T3
and HFF cells were stimulated to re-enter the cell cycle with
20% FCS in DMEM after the serum-deprivation phase.
Plasmids and DNA probes
Promoters were amplified from genomic DNA extracted
from NIH3T3 cells and human foreskin fibroblasts, re-
spectively, by standard PCR. DNA fragments were cloned
into the pGL4.10 luciferase reporter vector (Promega).
Site-directed mutagenesis was performed following the
QuikChange protocol (Stratagene). Sequences of cloning
primers as well as of mutagenic primers are provided in
Supplementary Table S1. Plasmids used for the amplifica-
tion of biotinylated DNA probes with CHR elements that
deviate from the common TTTGAA sequence in one nu-
cleotide (Supplementary Table S1) were prepared by liga-
tion of double-stranded oligonucleotides into the pGL4.10
vector.
DNA affinity purification
DNA affinity purifications were performed as described
earlier (2). Biotinylated DNA probes were amplified by
PCR using a biotinylated standard reverse primer and gene-
specific forward primers. In order to investigate binding of
DREAM components to isolated CDE/CHR elements in
an irrelevant DNA context, we amplified DNA probes with
a length of 193 nucleotides comprising the pGL4.10 vector
backbone and the inserted CDE/CHR elements. Oligonu-
cleotide sequences are available in Supplementary Table S1.
The biotinylated DNA probes were subjected to DNA affin-
ity purification with nuclear extracts of density-arrested
NIH3T3 cells or proliferating F9 cells, respectively, followed
by western blot assaying for binding of the DREAM or
MMB components. As an input control, 1% of the nuclear
extracts used for the DNA affinity purification was ana-
lyzed.
Chromatin immunoprecipitation (ChIP)
ChIPs were performed as described in (2). Bound promoter
regions were quantified with the QuantiTect SYBR Green
PCR Kit (Qiagen, Hilden, Germany) and the ABI 7300
real-time PCR system (Life Technologies, Carlsbad, CA,
USA). Oligonucleotide sequences are available in Supple-
mentary Table S1.
SDS-PAGE and western blot
SDS-PAGE and western blot were performed following
standard protocols (21). The following antibodies were ap-
plied for detection of DREAM and MMB components,
respectively: E2F4 (C-20) and p130 (C-20) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA, 1:1000 dilution).
The Lin37, Lin9 and Lin54 antibodies (1:1000 dilution) and
the monoclonal B-Myb LX015.1 antibody (hybridoma me-
dia 1:5) were kind gifts from James DeCaprio (4) and Roger
Watson (22).
Transfections and luciferase assays
Analyses of cell cycle-dependent promoter activities
with luciferase reporter assays in serum-starved and
re-stimulated NIH3T3 cells were performed as described
earlier (2).
FACS analysis
Cells were fixed overnight at 4◦C in one volume PBS/1 mM
EDTA and three volumes of absolute ethanol. DNA was
stained with Hoechst 33343 (Invitrogen) at a final concen-
tration of 10 g/ml for 15 min at 37◦C. DNA content per
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cell was determined by flow cytometry on an LSR II instru-
ment (Becton Dickinson, Franklin Lakes, NJ, USA). Data
analysis was performed with BD FACS Diva 6.1 and Win-
MDI 2.9 software.
Definition of promoter regions
Promoter regions of protein-coding transcripts were com-
piled as follows: Starting with the set of all coding tran-
scripts given in the UCSC Genes (knownGene) track for
the human genome (version GRCh37/hg19) (23), only tran-
scripts with a functional annotation in the GREAT tool
version 2.0.2 (24) were selected resulting in a set of veri-
fied protein-coding transcripts. Promoter regions of these
selected transcripts were defined by the region including
the annotated TSS and the 200 bases upstream and down-
stream ([−200, +200] interval). Due to the high phyloge-
netic conservation of protein-coding regions that would
interfere with the conservation-based motif detection, all
parts of a promoter sequence that overlap with coding ex-
ons of other transcripts were removed. Promoter regions in
which the TSS overlaps with a coding exon were completely
excluded from the analyses. The protein-coding genes cor-
responding to this set of promoter regions are referred to
as All Genes. Sequences of promoter regions (fasta format)
and genomic coordinates of promoter regions (BED for-
mat) are provided in Dataset 1 and Dataset 2, respectively.
For visualization of promoter regions in Supplementary
Figure S5, the UCSC Genome Browser was utilized (25).
Protein-binding data
Protein-binding data were collected from the literature,
namely, ChIP data for DREAM (E2F4, LIN9, LIN54,
p130) (4), ChIP data for LIN9 and B-MYB of MMB com-
plex (8) and FOXM1 data (6). When necessary, genomic co-
ordinates were lifted to the latest version of human genome
assembly (GRCh37/hg19) using UCSC liftover (26). Inter-
sections of binding data and promoter regions were calcu-
lated using BEDTools (27). For MMB, bound regions were
defined by the regions bound by both LIN9 and B-MYB
proteins. A promoter sequence was defined to be bound
by a certain protein if it overlaps with a region bound by
that protein. DREAM binding was defined analogously to
the original publication (4) by requiring binding of at least
E2F4, LIN9 and p130.
Cell cycle expression data
Cell cycle-dependent expression data were compiled from
three publications referred to as WF (28), BJ (29)
and SV (8). The data extracted from WF (CellCycle-
GeneList 1134.txt) contains annotations of peak expres-
sion for 1134 loci, which were assigned to a total of 600
protein-coding genes using the IDConverter (30) to map
Genbank accession numbers to UCSC ID’s. The 480 loci
with annotated peak expression from BJ (Supplementary
SI Table 5) were mapped via the official gene symbol to 367
protein-coding genes. The raw data published by SV were
processed following the instructions of the original publica-
tion (normalization using RMA from the R Affy package
(31) and identification of genes with cell cycle-dependent ex-
pression using the R timecourse package (32). Conversion of
the Affy IDs to UCSC IDs was performed with the R pack-
age biomaRt (33). Using the 1300 top ranked loci and their
time point of maximal expression, a total of 767 protein-
coding genes were assigned to a cell cycle phase of peak
expression by mapping 0h->G1/S, 2h->S-phase, 4h->G2,
6h->G2/M and 8h->M/G1.
For genes having different annotations in different data
sets, a single cell cycle phase of peak expression was cho-
sen. Similar to the method used in SV and BJ, annotations
from WF were used as reference to classify genes, i.e. the
WF annotation was used whenever available. For the 29
genes annotated only in SV and BJ, the cell cycle phase with
maximum expression was chosen from SV in cases of differ-
ing annotations. In addition, a very recently published data
set (34) was incorporated in the analysis of verified CHR
elements and referred to as GT. Annotations of peak ex-
pression for 1871 loci were mapped to 1543 protein-coding
genes, complementing the annotations from the other stud-
ies. The new data set was also used to redefine peak expres-
sion of genes previously annotated as ‘M/G1’. Thus, a total
of 2486 protein-coding genes were assigned to a unique cell
cycle phase of maximum expression.
Detection of binding sites in promoter regions
All sequences deviating in at most two positions from
the canonical TTTGAA were considered as putative CHR
elements. Other transcription factor binding sites were
modeled based on published binding sites or JASPAR
PWMs (35): CDE [CGT][CG][CG][CG][CG][CG] (1); E2F
TT[CG][CG][CG][CG][CG] Jaspar ID: MA0470.1; MBS
[CT]AAC[GT]G (36); FBS AAA[CT]A (6). Single binding
sites were searched on the plus and minus strand of pro-
moter regions. PhastCons data for the placental mammals
with human as a reference (37,38) was used to calculate the
average evolutionary conservation over all bases in a bind-
ing site. Detected sites were rejected if their conservation
was below an average of 0.9.
De novo motif prediction and motif comparison
For de novo motif prediction in the 92 promoter regions
that are DREAM-bound and differentially expressed in cell
cycle but lacking conserved CHR and E2F elements, the
MEME program (39) in its version 4.6.1 was used with ‘-
dna -mod anr -nmotifs 5 –minw 6 –maxw 9 -revcomp –
maxsites 150’ options to search for motifs of length 6 to 9 on
both strands. Comparison of motifs from MEME predic-
tions with published transcription factor binding sites was
performed with the motif comparison tool TOMTOM (40)
from the MEME suite (website, version 4.9.0) using stan-
dard settings.
RESULTS
DREAM can bind to non-canonical CHR elements in vitro
Since only a few functional CHR sites that deviate from
the canonical TTTGAA sequence had been identified pre-
viously, we performed a comprehensive search for alterna-
tive CHR elements. First, we established an assay system
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that allows for comparison of in vitro DREAM binding
to CHR-derived elements independent of promoter con-
text. For the mouse cyclin B2 promoter we had shown ear-
lier that a single canonical CHR element is sufficient for
cell cycle-dependent regulation and binding of DREAM,
although binding is supported by an adjacent CDE ele-
ment (2). We observed that the promoter context and ad-
ditional elements were not required for DREAM binding
since the isolated CDE/CHR tandem, placed in the irrel-
evant DNA context of the pGL4.10 vector backbone, was
bound by representative DREAM components with simi-
lar affinity as the wild-type Ccnb2 promoter (Figure 1A).
In order to identify CHR-like sequences that may be func-
tional while differing from the wild-type CHR, we assayed
all possible 18 single-nucleotide permutations of the canon-
ical TTTGAA element for DREAM binding (Figure 1B).
Probes were based on the mouse cyclin B2 CDE/CHR el-
ement since DREAM binding to the tandem element in-
stead of the isolated CHR results in more robust western
blot signals. We observed that the strongest binding occurs
to the canonical CHR TTTGAA as well as to the sequence
TTTAAA. Other related sites are able to bind DREAM
with varying affinity. Especially binding to TTCGAA and
TTTGAT elements is clearly above background. These re-
sults suggest that other non-canonical but functional CHR
elements exist in mammalian genomes.
A comprehensive analysis of DREAM-bound late cell cycle
genes identifies many candidates with non-canonical CHRs
For a genome-wide identification of genes regulated by
DREAM through CHR elements in human, experimen-
tal data for DREAM binding and cell cycle regulation
were incorporated in a computational screen. We utilized
DREAM-binding data (4) and three data sets on cell cycle-
dependent mRNA expression by Whitfield et al. (28), Bar-
Joseph et al. (29), and Sadasivam et al. (8), referred to as
WF, BJ and SV, respectively. After we had finished the ini-
tial identification of non-canonical CHR elements, a new
data set on genes differentially expressed during the cell cy-
cle became available (34). As this screen significantly in-
creases the number of available cell cycle annotations, we
decided to include these data for further computational
analyses referring to it as GT. The four data sets had lit-
tle overlap in the group of cell cycle regulated genes and in
time points of peak expression (Figure 2A). This seems to
be caused by the different methods used to classify the ex-
pression peaks rather than by differences in the measured
expression profiles. While annotations of consecutive cell
cycle phases (e.g. G1/S and S; G2, G2/M, and M/G1) are
often inconsistent, classification into early and late cell cy-
cle phases yielded similar data sets from the four analyses.
In order to prevent loss of late cell cycle genes falsely anno-
tated in S phase, we decided to define ‘late cell cycle genes’
to be expressed in S, G2 and M at this point of the analysis.
Thus, peak expression was assigned to 2486 genes, of which
1408 have a maximum expression in the late cell cycle.
The CHR-like sequences searched for in the genome-
wide screen cover the canonical TTTGAA and all 18 single-
nucleotide mutations, also comprising the already described
functional CHR elements TTTAAA and CTTGAA. Addi-
tionally, elements differing in two positions from the canon-
ical element TTTGAA were included in the search to sys-
tematically identify elements such as the TAGGAA CHR
motif which had been described in the B-myb promoter
(15,17). As swapping two bases in a sequence of six nu-
cleotides results in 135 different permutations, many of
which can represent target sites for transcription factors dif-
ferent from DREAM, we restricted our search to report
CHR-like sites with two-nucleotide permutations only if
a CDE with a 4-bp spacer upstream of the element was
present.
The distribution of CHR-like elements in the promoter
regions from all protein-coding genes (All Genes) was
nearly uniform, independent from the evolutionary conser-
vation (Figure 2B). Selection by phylogenetical conserva-
tion (phastCons score ≥ 0.9) reduced the number of poten-
tial CHRs from 47 444 to 7570. For all further analyses,
the phastCons score was set to ≥ 0.9 for putative binding
sites. Subsets of All Genes were defined containing genes
binding DREAM (D), expressed during the late cell cycle
(LCC), or the overlap of both groups (D+LCC). In con-
trast to All Genes, in these subsets a few CHR-like elements
were enriched (Figure 2C and Supplementary Table S3): the
canonical TTTGAA as well as the elements TTCGAA and
TTTCAA. The element TTTCAA can resemble the inverse
canonical CHR (TTCAAA) when shifted by one nucleotide
which was observed in 85% of all cases. The same accounts
for TTTTAA overlapping with a TTTAAA in 83% of the
hits.
Since CHR-regulated genes are described to be bound
by DREAM and to have peak expression in late cell cy-
cle phases, candidate genes for experimental validation of
CHR-like elements were selected from the D+LCC data set.
Such candidates were not identified for all screened CHR-
like sequences since either the putative element was not phy-
logenetically conserved or the corresponding gene harbored
another previously described CHR that was located closer
to the TSS. Furthermore, 82% of genes with the CHR-like
element TTTGCA were identified as histone genes. This el-
ement resembles a canonical Oct1 binding site. Since it had
been shown that histone genes are regulated through such
Oct1 sites (41) and DREAM did not bind to this element
with high affinity in the DNA affinity purification screen
(Figure 1B), we did not further test these elements as po-
tential CHRs.
Finally, 22 CHR-like elements were tested in promoters
carrying such sites. (Supplementary Table S2). For more
than half of these elements binding of DREAM to the
promoter was not observed or mutation of the element
did not affect promoter activity. Consequently, we do not
regard these elements as functional CHRs. This also ap-
plies to the CHR-like elements in the promoters of Exo1
and Nek2, which will be presented in more detail below.
However, we discovered six novel non-canonical and func-
tional CHRs differing in one or two nucleotides from the
canonical element: TTCGAA (Bub1), TTTGTA (Chek2),
TTTGAT (Melk), TTTGAG (Pold1), TTCGAG (Rad18)
and TTCGAT (Rad54l). Function and binding properties
of these sites were tested in the listed genes serving as exam-
ples for the new CHR sites (Figures 3–5).
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Figure 1. DREAM can bind to non-canonical CHR elements in DNA affinity purification assays. (A) Analysis of DREAM complex binding to the
isolated cyclin B2 CDE/CHR element flanked by irrelevant DNA and to a 220-bp cyclin B2 promoter probe. Biotinylated DNA probes based on the
mouse Ccnb2 promoter (Ccnb2) and on the CDE/CHR element from the same promoter (CDE/CHR) were cloned in the pGL4.10 vector backbone and
subjected to DNA affinity purifications with density-arrested NIH3T3 cells. Binding of DREAM components (p130, E2f4, Lin37, Lin54) to both probes
was analyzed with polyclonal antibodies. As a non-DREAM binding negative control, a DNA probe based on the empty pGL4.10 vector was utilized
(CTRL). All samples are from the same blot. (B) DREAM complex binding to CHR elements differing from the canonical sequence TTTGAA in one
nucleotide analyzed in an in vitro DNA affinity purification assay. Biotinylated probes based on the CDE/CHR probe with all possible 1 bp permutations
were prepared and subjected to DNA affinity purifications with nuclear extracts from density-arrested NIH3T3 cells. A DNA probe based on the empty
pGL4.10 vector was used as a non-DREAM binding negative control (CTRL). Eluates were probed in western blots for the DREAM components p130,
E2f4 and Lin9. All samples were processed in parallel.
Mouse ortholog genes with non-canonical CHRs are cell cy-
cle regulated and bind DREAM in vivo
Having identified human candidate genes harboring poten-
tial non-canonical CHRs in their promoters which differ
in one nucleotide from the canonical element (Figure 3A),
we tested whether their mouse orthologs are expressed in
late cell cycle phases and whether they bind DREAM in
mouse NIH3T3 cells to confirm the observation we have
made for many CDE/CHR-regulated genes that regulation
for a given human or mouse promoter appears identical in
mouse and human cells (2). We performed ChIPs in density-
arrested NIH3T3 cells and showed that E2f4, p130 and
Lin9 as representative DREAM components are enriched
at the Bub1, Chek2, Melk and Pold1 promoters (Figure 3B).
Additionally, we measured cell cycle-dependent mRNA ex-
pression of these genes in synchronized NIH3T3 cells. Ex-
pression is low in G0 and G1 phase and starts to increase
in S phase. Maximal mRNA expression is reached in late
S, G2 and M phases (Figure 3C, Supplementary Figure
S1). mRNA expression of the non-cell cycle regulated U6
snRNA was measured as a control (Supplementary Figure
S1). These findings strongly suggest that the mouse and hu-
man genes are regulated similarly and that the identified
elements represent indeed functional novel non-canonical
CHRs.
Non-canonical CHR elements mediate cell cycle-dependent
regulation and bind DREAM
In order to test the potential elements differing in one nu-
cleotide from the canonical sequence for function, wild-type
and CHR mutant promoters of Bub1, Chek2, Melk and
Pold1 were analyzed in reporter assays during the cell cy-
cle (Figure 4A). To create promoters with non-functional
CHRs, the sequence of the elements was changed to TG-
CATA (CHR). In G0 and G1 phases, the activity of all
wild-type promoters was very low and started to increase
in S phase to reach their maxima in late S and G2/M
phases (Figure 4A, Supplementary Figure S1). The expres-
sion from the promoters in the reporter assays was consis-
tent with their mRNA expression patterns (Figure 3C). Im-
portantly, all promoters with mutated CHRs were dereg-
ulated. As an example for this deregulation, the maximal
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Figure 2. Identification of potential CHR elements in cell cycle genes. (A) Numbers of genes annotated as cell cycle-regulated by one or several of the data
sets reported by Whitfield et al. (WF), Bar-Joseph et al. (BJ), Sadasivam et al. (SV) and Grant et al. (GT). The numbers of genes with identically annotated
cell cycle phases of peak expression for each intersection are shown in parentheses. (B) Distribution of CHR-like elements in promoter regions of All Genes
with (phylCons> = 0.9) or without (no phylCons) phylogenetical conservation. (C) Fold change of phylogenetically conserved CHR-like elements in the
sets of DREAM-binding genes (D), late cell cycle-expressed genes (LCC), or late cell cycle genes binding DREAM (D+LCC). For all elements the fold
change was calculated using their relative frequencies in the corresponding set divided by their relative frequencies in All Genes. A fold change above one
indicates an enrichment of the element in the corresponding set.
fold-change from G1 to G2/M for the Melk gene shifts from
66.7 for the wild-type construct to 2.5 for the CHR mutant
reporter (Figure 4A). A common feature of all tested mu-
tants is de-repression in the early cell cycle phases.
The ability of DREAM to bind the non-canonical CHR
elements in vitro was examined using DNA affinity purifi-
cation with extracts of density-arrested NIH3T3 cells. Ad-
ditionally, we analyzed the CHR elements in the promot-
ers of CCNA2 (CTTGAA), CCNB1 (TTTAAA) and B-myb
(TAGGAA) genes. These non-canonical CHRs had been
shown to be functional, but interaction of the elements with
DREAM had yet to be investigated (11,14–16). The repre-
sentative components of the DREAM complex p130, E2f4
and Lin37 bound to all wild-type promoters, while bind-
ing was disrupted when the CHR elements were mutated
(Figure 4B). Taken together, the results from functional and
protein-binding assays provide evidence that the analyzed
elements are non-canonical CHRs.
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Figure 3. Genes with non-canonical CHR elements bind DREAM and are expressed in late cell cycle phases. (A) Alignments of putative CHR elements
in Bub1, Chek2, Melk and Pold1 promoters from different mammals. CHRs are highlighted in gray. (B) Chromatin immunoprecipitations in density-
arrested NIH3T3 cells to promoters with putative CHR elements. Antibodies targeting the representative DREAM components E2f4, p130 and Lin9 as
well as a non-targeting rabbit antibody (IgG) were applied. Binding of DREAM components to the Gapdhs promoter was measured as a negative control.
Precipitated DNA fragments were quantified by qPCR and normalized to the input. (C) mRNA expression of Bub1, Chek2, Melk and Pold1 in different
cell cycle phases was measured in NIH3T3 cells synchronized by serum deprivation followed by serum re-stimulation. FACS analyses for the different time
points are shown in Supplementary Figure S1.
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G0 G1 S                   G2/M
max. fold-change
Bub1 wild-type 46.0
Bub1  ΔCHR 2.8
Chek2  wild-type 11.1
Chek2  ΔCHR 2.5
Melk  wild-type 66.7
Melk  ΔCHR 2.5
Pold1  wild-type 23.8
Pold1  ΔCHR 3.8
pGL4.10 5.1
Figure 4. Non-canonical CHR elements are essential for cell cycle-dependent gene transcription and DREAM binding. (A) Promoter activity of Bub1,
Chek2, Melk and Pold1 was analyzed with luciferase reporter assays in NIH3T3 cells synchronized by serum starvation followed by serum re-stimulation.
Activities of wild-type promoters were measured in different cell cycle phases and compared to the activity of the corresponding CHR mutants (CHR).
pGL4.10 empty vector served as a negative control. FACS analyses for the different time points are shown in Supplementary Figure S1. (B) DREAM
binding to promoters with non-canonical CHR elements was analyzed by DNA affinity purification followed by western blot. Proteins from nuclear
extracts of density-arrested NIH3T3 cells binding to wild-type promoters (WT) and CHR mutants (CHR) were probed with antibodies targeting p130,
E2f4 and Lin37 as representative components of DREAM. A DNA probe of the Gapdhs promoter served as a negative control (CTRL).
Functional CHRs can deviate from the canonical element by
two nucleotides
In combination with an E2F site, the non-canonical CHR
TAGGAA of the B-myb promoter was shown to control
cell cycle-dependent transcription (15,17). This is the only
element that had been described previously as a CHR
which differs from the canonical sequence by two nu-
cleotides. In the computational screen, we identified seven
additional candidate genes harboring CHR-like elements
with two nucleotide variations and tested them for function
(Supplementary Table S2). Three putative CHR elements
(TTCGGA, TTGGAT, TCTGTA) in the candidate genes
ATAD2, Blm and BRCA1 could not be verified to be func-
tional in the reporter assays (data not shown). The CHR-
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like element in NEK2 is not conserved between human
(GTTAAA) and mouse (GTTGAC) genes (Supplementary
Figure S2A). We cloned the promoters of both ortholog
genes and showed that their cell cycle-dependent transcrip-
tion was mediated by these elements. While the wild-type
promoters showed a pattern of activity that is typical for
late-expressed cell cycle genes, mutation of the CHR-like
elements resulted in deregulation (Supplementary Figure
S2B). However, although binding of DREAM components
to the promoters in ChIP assays was detected, we did not
observe binding of the proteins in DNA affinity purifica-
tions (Supplementary Figure S2C and D). Similar observa-
tions were made for the CHR-like element ATCGAA in the
mouse Exo1 promoter (Supplementary Figure S3). Taken
together, the CHR-like sequences exhibit features of func-
tional CHRs and were shown to be central elements for cell
cycle-dependent regulation in the DREAM-bound promot-
ers of NEK2 and Exo1 genes. Yet, we do not designate them
as CHRs since direct DREAM binding to the CHR-like el-
ements could not be shown in vitro.
Nevertheless, we could identify two novel functional non-
canonical CHR elements with two-nucleotide variations in
the promoters of Rad18 (TTCGAG) and Rad54l (TTC-
GAT). Both CHRs are highly conserved and located close
to the transcription start (Figure 5A). Human RAD18 and
RAD54L mRNA were already shown to be differentially ex-
pressed during the cell cycle (42,43). We confirmed the cell
cycle-dependent expression with a peak in G2/M phases for
Rad18 in the mouse NIH3T3 cell system and observed a
similar pattern for Rad54l (Figure 5B). More importantly,
we detected binding of DREAM components to the region
close to the TSS by ChIP (Figure 5C). Subsequently, we an-
alyzed the regions 500 bp upstream from the translational
starts of the both genes and found that these promoters
were repressed in G0 and early G1 and became activated
when the cells progressed to S phase. When the CHR-like
elements were mutated, cell cycle-dependent regulation was
completely abolished (Figure 5D) and DREAM binding
was lost (Figure 5E). Thus, the cell cycle-dependent expres-
sion of Rad18 and Rad54l genes is regulated through non-
canonical CHRs that deviate by two nucleotides from the
canonical element.
CHR elements are enriched in promoters binding DREAM,
MMB or FOXM1
The MuvB core complex participates in DNA binding of
DREAM, MMB and FOXM1-MuvB by differentially as-
sociating with E2F4-DP1-p130, B-MYB or FOXM1. With
E2F elements (binding E2F/DP dimers), CHRs (binding
LIN54), MBS elements (MYB-binding sites) and FBS ele-
ments (forkhead binding sites for FOXM1), four different
elements have been suggested as binding sites for MuvB-
containing complexes (2–4,8,9). However, it appears that
not all interactions of those transcription factors with their
canonical DNA binding sites are necessary for the MuvB-
containing complexes to function. For instance, although a
significant overlap of genes bound by MMB and FOXM1
is observed, no enrichment of MYB-binding sites (MBS) or
forkhead-binding sites (FBS) was detected in the data set
representing FOXM1-binding genes (6).
Here, the presence of all 10 identified CHR sequences
in combination with either E2F, MBS or FBS elements
was analyzed and compared in sets of promoters bound
by DREAM, MMB and FOXM1 (Figure 6). We observed
a substantial enrichment of promoters containing single
CHR (+CHR-E2F) or E2F (−CHR+E2F) elements or
combinations of both (+CHR+E2F) in the data set rep-
resenting genes bound by DREAM (D) compared to the
All Genes data set. CHR elements are even more enriched
in promoters bound by MMB or FOXM1 and accumulate
to 82% in the set of genes bound by DREAM, MMB and
FOXM1. In contrast, the fraction of promoters contain-
ing E2F elements only (−CHR+E2F) was found reduced
in this comparison (Figure 6A) and was almost depleted of
genes bound by DREAM and MMB as well as by FOXM1.
This is in agreement with published data showing an enrich-
ment of E2F sites in DREAM-bound, but not in MMB-
and FOXM1-bound genes (4,6,8).
MMB and FOXM1-MuvB appear to bind promoters through
CHR sites
In genes bound by MMB or FOXM1, the co-occurrence
of CHR and MBS elements (+CHR+MBS) was enriched
about 10-fold compared to All Genes (Figure 6B). Neverthe-
less, the fraction of genes in the MMB and FOXM1 data sets
containing CHR elements only (+CHR−MBS) was about
four to five times larger than for those containing both sites.
In contrast, single MBS elements (−CHR+MBS) were not
enriched in MMB and FOXM1 compared to their fraction
observed in All Genes. Interestingly, in the data set of genes
bound by all three complexes, not a single promoter hold-
ing a conserved MBS was identified provided that no CHR
was found in the promoter (Figure 6B). Comparable obser-
vations were made for combinations of FBS elements and
CHR sites (Figure 6C). The finding that CHRs, but not FBS
elements, are strongly enriched supports the conclusion that
FOXM1 does not bind to FBS but is recruited via MuvB.
This is consistent with recent observations (6).
As MBS elements were suggested to be necessary for re-
cruiting MMB to promoters (8,9), we tested whether this
complex can bind to an isolated CHR not surrounded by
natural promoter DNA, specifically devoid of an MBS ele-
ment. To this end, we assayed binding of MMB to the iso-
lated CDE/CHR element of Ccnb2 flanked by irrelevant
vector DNA or to the Ccnb2 core promoter which holds
an MBS (Figure 6D). MMB bound to the probe carry-
ing the isolated element with comparable affinity as to the
Ccnb2 promoter probe. Thus, MMB can bind to isolated
CDE/CHR elements without the necessity of additional el-
ements such as an MBS.
Recently, four MBS elements in the Birc5 (survivin) pro-
moter were implicated to cooperate in activating the pro-
moter through binding of MMB (9). These elements are not
phylogenetically conserved and thus were not identified in
our screen. The impact of a functional CHR in the Birc5
promoter (44) was not analyzed in this report. We tested
whether mutation of the MBS and the CHR changes pro-
moter activity in different cell cycle phases. Birc5 promoter
luciferase reporter constructs containing the reported four
MBS elements as well as the CHR in the wild-type reporter
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Figure 5. The Rad18 and Rad54l CHRs deviate in two nucleotides from the consensus TTTGAA element but are still functional. (A) Comparison of
nucleotide sequences in Rad18 and Rad54l promoters from several mammals. (B)Rad18 and Rad54l mRNA expression measured in synchronized NIH3T3
cells at indicated time points after serum starvation and serum re-stimulation. (C)In vivo binding of DREAM components (E2f4, p130, Lin9) in density-
arrested NIH3T3 cells to the Rad18 and Rad54l promoters measured by ChIP. A non-targeting rabbit antibody (IgG) served as a negative control. Binding
of DREAM proteins to Rad18 and Rad54l was quantified by qPCR and compared to binding to the Gapdhs promoter, which is not targeted by DREAM.
(D) Promoter activity of Rad18 and Rad54l measured in synchronized NIH3T3 cells with luciferase reporter assays. Activity of the wild-type promoters
is compared to CHR mutants (CHR). (E) DNA affinity purification from nuclear extracts of density-arrested NIH3T3 cells tested for representative
DREAM components E2f4, p130 and Lin37 by western blot. A DNA probe of the Gapdhs promoter served as a negative control (CTRL).
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Figure 6. CHR elements are enriched in promoters of genes bound by DREAM, MMB and FOXM1. (A) Percentage of promoters with or without CHR
elements (+CHR or –CHR) and with or without E2F sites (+E2F or –E2F) in different promoter subsets: all promoters (All Genes), DREAM-bound
promoters (D), promoters bound by the MMB components B-MYB and LIN9 (MMB), promoters bound by FOXM1 (FOXM1) and promoters bound
by two or all three of the complexes. (B) Fraction of promoters with or without Myb-binding sites (+MBS or –MBS) and with or without CHRs (+CHR,
–CHR) in different promoter subsets. (C) Percentage of promoters with or without forkhead-binding sites (+FBS or –FBS) and with or without CHRs
(+CHR, –CHR) in different promoter subsets. (D) Binding of MMB to the isolated cyclin B2 CDE/CHR site flanked by irrelevant DNA in comparison to
a 220 bp cyclin B2 promoter probe. Biotinylated DNA probes derived from the mouse Ccnb2 promoter (Ccnb2) and from the cyclin B2 CDE/CHR element
cloned into the pGL4.10 vector backbone (CDE/CHR) were subjected to DNA affinity purifications with nuclear extracts of proliferating F9 cells which
do not form DREAM. MMB components B-Myb, Lin54, Lin37 and Lin9 were detected by western blot. To control the absence of DREAM binding to
the probes, E2f4 as part of the DREAM complex was analyzed. As a non-MMB-binding negative control, a DNA probe based on the empty pGL4.10
vector was employed (CTRL).
and mutant reporter constructs lacking several or all MBS
elements or the CHR were generated. While wild-type pro-
moters and all MBS mutants showed nearly identical activ-
ities with low expression in G0/G1 and maximal expression
in G2/M, cell cycle-dependent regulation was completely
disrupted upon CHR mutation (Supplementary Figure S4).
Thus, the CHR is the main element in the Birc5 promoter
necessary for cell cycle-dependent regulation while MBS el-
ements are not required.
Taken together, our data show that among the analyzed
binding sites, only the CHR is strongly enriched in promot-
ers bound by MMB and FOXM1. There is no indication
that MBS or FBS elements are generally required to recruit
MMB or FOXM1-MuvB.
CHR sites are predominantly found in genes expressed during
G2/M
The presence of CHR and E2F elements was analyzed
for DREAM-bound genes expressed in specific cell cycle
phases (Figure 7A). Nearly all genes harboring a CHR
without an E2F site in their promoters (+CHR−E2F) were
expressed late in the cell cycle with maximal expression in
G2 or M. In case of sole E2F elements in the promoter
(−CHR+E2F), 68% of the genes showed peak expression in
early cell cycle phases (G1 and S). Interestingly, genes that
contain both elements in their promoters (+CHR+E2F)
accumulated to 85% in fractions expressed in late cell cy-
cle phases, a distribution found similarly for genes carrying
only a CHR (Figure 7A). Furthermore, a significant differ-
ence in the time point of expression start could not be de-
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Figure 7. CHR genes bound by DREAM, MMB and FOXM1 are cell cycle regulated with peak expression in late cell cycle phases. (A) Correlation of the
time point of maximal gene expression with the occurrence of CHR elements (+CHR or –CHR) and E2F sites (+E2F or –E2F) in promoters. Enriched
functional clusters obtained using each of the four subsets along with their P-values are given. (B) Peak expression of CHR genes bound by DREAM,
MMB and FOXM1 in early and late cell cycle phases. Numbers of genes in the different subsets are given. (C) Rate of CHR sites in genes bound by
DREAM, MMB and FOXM1. Percentages of genes with (CHR) and without (no CHR) CHR element are given.
tected when comparing expression profiles in the SV data
set for these genes (data not shown). These results suggest
that time points of transcriptional activation and maximal
expression are mainly regulated through the CHRs even if
additional conserved E2F sites are present in these promot-
ers.
In general, the number of DREAM-bound genes ex-
pressed in early or late cell cycle phases was nearly equal.
Genes with promoters carrying no conserved CHR or E2F
elements (−CHR−E2F) were expressed in early cell cycle
phases in nearly 60% (Figure 7A). Interestingly, 40% of
those genes represent histones with a peak expression in S
phase. For DREAM-bound and cell cycle regulated genes,
functionally related groups based on GO terms were ana-
lyzed using the DAVID Functional Annotation Tool (45).
Consistent with the enrichment of late and early peak ex-
pression for promoters harboring either CHRs or E2F el-
ements, related GO terms were found enriched for those
genes (Figure 7A). Namely, the GO terms nuclear division,
mitosis and M phase of mitotic cell cycle were found highly
enriched for genes carrying CHR elements in their promot-
ers (+CHR−E2F). In contrast, genes with only E2F el-
ements (−CHR+E2F) were annotated mainly in the cat-
egories DNA metabolic process, response to DNA damage
stimulus and DNA replication. Again, the presence of E2F
elements in addition to CHRs (+CHR+E2F) had no de-
tectable effect compared to genes with single CHRs since
for both sets the same GO terms were enriched. In promot-
ers without identified CHRs or E2F sites, only the terms
chromosomal part, nucleosome, protein–DNA complex were
found enriched due to the high number of histone genes in
this group (Figure 7A). A de novo motif prediction from
the −CHR−E2F data set of genes followed by a compari-
son with known transcription factor binding sites identified
CCAAT-boxes, Oct1 sites as well as GC-rich and AT-rich
regions. While the CCAAT-boxes are common elements in
many eukaryotic promoters that provide basal transcrip-
tional activity, the Oct1-binding site mediates regulation of
cell cycle dependent expression in histone genes (41). Thus,
in promoters without CHR and E2F sites, evidence for an
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alternative mechanism by other transcription factor bind-
ing sites that could substitute for E2F elements or CHRs
did not emerge by de novo motif prediction.
Most CHR genes bound by DREAM, MMB and FOXM1
are cell cycle regulated with peak expression in G2/M
After having identified CHR elements in most genes bound
by DREAM, MMB and FOXM1 and having observed that
most CHR genes bound by DREAM are expressed dur-
ing the late cell cycle, we asked whether binding of the
three complexes to a CHR gene generally results in a cell
cycle-dependent regulation. We analyzed CHR-containing
genes bound by DREAM and MMB or FOXM1 for cell
cycle-dependent expression and found a late cell cycle an-
notation for 66 out of 76 genes in the DREAM+MMB
gene set and for 70 out of 77 genes in DREAM+FOXM1
(Figure 7B). From the non-regulated genes, five (H2AFZ,
KIF24, MXD3, NCAPG, PARPBP) were identified as cell
cycle regulated with peak expression in G2/M by quan-
tification of mRNA in synchronized HFF cells (Supple-
mentary Figure S5). Interestingly, another six (METTL15,
DCAF16, IFT80, PDZD11, PTRHD1, HSCB) are posi-
tioned head-to-head in close proximity to genes that were
identified as cell cycle regulated (Supplementary Figure S5).
Thus, in these examples it is likely that binding of DREAM,
MMB and FOXM1-MuvB to the region shared by two
genes is responsible only for the regulation of one gene. For
the three remaining genes (HNRNPH2, RBMX, LSM5), no
significant increase in mRNA expression during the late cell
cycle was measured. In CHR genes bound by all three com-
plexes, only one gene (METTL15) was not annotated as a
late cell cycle gene (Figure 7B).
Taken together, binding of transcription factors and ex-
pression data is consistent with a model of sequential
DREAM, MMB and FOXM1–MuvB binding to CHR
genes resulting in repression of transcription in early cell cy-
cle phases and activation of expression during the late cell
cycle.
Regulation of late cell cycle genes by binding of DREAM,
MMB and FOXM1-MuvB depends on CHR elements
Interestingly, in the group of late cell cycle genes bound by
DREAM and MMB as well as by FOXM1, our compu-
tational analysis identified highly conserved and validated
CHR sites in 48 out of 55 genes. In one of the seven re-
maining genes, NEK2, we had identified a CHR-like ele-
ment (Supplementary Figure S2). In another four of those
genes (TOP2A, CKAP2, DZIP3, KIAA1524), CHR ele-
ments are located close to the TSS, but were not detected in
the screen because their conservation scores are below 0.9.
However, these elements still show considerable conserva-
tion with scores between 0.36 and 0.71 (Supplementary Ta-
ble S3). As these genes exhibit all characteristics of CHR-
regulated genes, it is likely that their cell cycle-dependent
expression is regulated through these elements. In only two
genes (SKA2, SFPQ,) no CHR was located in the region of
+/−200 bp to the TSS; however, highly conserved CHRs
are found exactly on the TSS of an alternative SKA2 tran-
script and 400 bp upstream of the SFPQ gene.
Thus, we identified evolutionary conserved CHR sites
close to the TSS in 95% of all late cell cycle genes which are
bound by DREAM, MMB and FOXM1 (Figure 7C). All
of these genes show peak expression in G2 and M phases.
Taken together, the results show that a CHR is always
present in promoters of late cell cycle genes if they are reg-
ulated by binding of DREAM, MMB and FOXM1.
CHR elements exhibit low sequence variability and can func-
tion in forward and reverse orientations
Based on the results of our computational screen and the
analysis of potential CHR genes and their promoters, we
identified 148 genes that show clear features of CHR-
regulated genes (Table 1). This group of genes also includes
CEP152, GSG2 (Haspin), NCAPG2, SASS6 and SMC2.
These genes were identified as late cell cycle genes by quan-
tification of mRNA in synchronized HFF cells although
they are not annotated accordingly in the four genome-wide
screens (Supplementary Figure S5). Additionally, GAS2L3
was reported as a DREAM target before (46) and identified
here as a CHR gene.
Generally, the identified CHR elements showed little se-
quence variation. Highest variability was observed for the
last nucleotide position of CHR sites (Figure 8A). We per-
formed a quantitative analysis of sequence variation cov-
ering CHRs and their flanking regions from all 148 genes.
Importantly, the canonical TTTGAA sequence was the pre-
dominant CHR element (Figure 8B). Nevertheless, also the
sequence TTTAAA and the newly identified TTCGAA oc-
curred frequently. Reverse orientation of non-palindromic
CHRs was detected in about 45% of the genes. Another im-
portant feature of the identified CHR sites was their loca-
tion on or very close to the annotated TSS (Figure 8C).
Although initial reports had suggested that CDE sites
four nucleotides upstream from CHRs are often required
for function (1), only the CHR elements themselves were
found to be conserved (Figure 8D). Searching directly for
CDE elements combined with validated CHRs, we found
CDE/CHR tandem combinations are not standard. From
the CHR-containing promoters bound by DREAM and ex-
pressed late in the cell cycle only 23% contained a CDE
(Supplementary Table S3). Therefore, we conclude that the
majority of CHRs can function without an upstream CDE.
DISCUSSION
CHR promoter elements have been identified as important
transcriptional regulatory elements almost 20 years ago
(11). These elements are usually found in TATA-less pro-
moters of genes that are differentially expressed during the
cell cycle with a maximal expression in G2 and M phases.
Four different CHR sequences had been characterized in
several late cell cycle genes, but a comprehensive approach
with the aim to identify a broader spectrum of these impor-
tant regulatory elements has been missing until now.
Identification of novel CHR sequences
A DNA affinity purification assay provided evidence that
additional CHR-like sequences can be bound by the
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Table 1. Late cell cycle genes harboring evolutionary conserved CHR elements
AKIRIN2 CCDC99 CEP152 ESCO2 KIF15 NCAPD2 PRC1 SPAG5
ANLN CCNA2 CHEK2 ESPL1 KIF18A NCAPG PRR11 SPC25
ANP32E CCNB1 CIT FAM110A KIF20B NCAPG2 PTTG1 SPRY4
ARHGAP11A CCNB2 CKAP2 FAM64A KIF22 NCAPH RACGAP1 TMPO
ARL6IP1 CDC20 CKAP2L FBXO5 KIF23 NDC80 RAD18 TOP1
ASF1B CDC25C CKAP5 FOXM1 KIF24 NEIL3 RAD54L TOP2A
ASPM CDCA2 CKS1B GAS2L3 KIF2C NRD1 RANGAP1 TPX2
AURKA CDCA3 CKS2 GSG2 KIF4A NUCKS1 REEP4 TRAIP
AURKB CDCA8 CSE1L GTSE1 KPNA2 NUF2 RNF26 TROAP
BIRC5 CDK1 CSTF1 H2AFX LMNB1 NUP35 RTKN2 TTK
BORA CDK2 DBF4B H2AFZ LOC81691 NUSAP1 SASS6 UACA
BUB1 CDKN2D DCP2 HJURP MAD2L1 PARPBP SCLT1 UBE2C
BUB1B CDKN3 DEPDC1 HMMR MELK PIF1 SETD8 UBE2S
BUB3 CENPA DEPDC1B INCENP METTL4 PLK1 SGOL1 WEE1
C11orf82 CENPE DLGAP5 IQGAP3 MIS18BP1 PLK4 SGOL2 ZRANB3
C12orf32 CENPF DNMT3B KIAA1524 MND1 POC5 SHCBP1
C2orf69 CENPM DZIP3 KIAA1731 MYBL2 POLD1 SKA1
C9orf100 CENPO EIF2AK3 KIF11 MXD3 POLQ SMC2
CASC5 CEP55 ENC1 KIF14 MZT1 POU2F1 SMC4
All genes are bound by DREAM. Genes also observed to bind MMB and FOXM1 are marked in bold.
Figure 8. CHR sites predominantly have the sequence TTTGAA and are found close to the transcription start site. (A) Alignment of functional CHR
elements. (B) Relative occurrence of the 10 validated CHR sequences in DREAM-bound genes expressed during the late cell cycle (D+LCC). (C) Positions
of the identified CHR elements relative to the transcription start site (TSS) in DREAM-bound genes expressed during the late cell cycle (D+LCC). (D)
Sequence logo derived from verified CHR sequences identified in promoters of the D+LCC data set with flanking nucleotides.
DREAM complex (Figure 1) and thus may constitute
functional elements. We therefore searched for such non-
canonical CHRs in the promoters of cell cycle genes.
Screening DREAM-bound genes with peak expression in
S, G2 and M phases, we identified and then experimen-
tally validated four new sequences that deviate in one nu-
cleotide from the most common element TTTGAA and two
sequences that deviate in two nucleotides, resulting in six
novel DNA sequences that can be designated as CHR ele-
ments. All six genes tested as examples for harboring these
novel CHR elements (Bub1, Chek2, Melk, Pold1, Rad18
and Rad54l) play important roles in cell cycle regulation and
DNA repair (44,47–58). Cell cycle-dependent expression
had already been established for POLD1, MELK, RAD18
and RAD54L. Interestingly, cell cycle-dependent transcrip-
tion of the human POLD1 gene had been shown to be reg-
ulated through a CHR (59). The CHR in the human pro-
moter deviates from the sequence in mouse and resembles
the canonical sequence TTTGAA (Figure 3A) in contrast to
the TTTGAG element we have identified in mouse. Thus,
POLD1 is a good example for a gene with evolutionary
changes in the CHR sequence that do not disrupt function-
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ality of the element. The Melk gene had been shown to be
differentially regulated during the cell cycle depending on
E2F4 and p130/p107, however, a CHR element had not
been reported (60). This is also the case for human RAD18
and RAD54L, whose mRNAs had been shown to be cell cy-
cle regulated without further investigation of the promoter
(42,43).
Most of the previously reported genes with CHRs were
detected in our computational screen showing that our
search strategy was appropriate. Nevertheless, additional
CHR sites may have escaped our search. As it is not feasible
to examine all potential CHR elements by mutation analy-
sis, we focused on example candidates for each identified
sequence. In particular, we cannot rule out that a CHR-like
sequence that was non-functional in one tested gene could
be functional in another promoter context. We may also
have missed functional CHRs due to incorrect classifica-
tions of cell cycle-regulated genes, erroneous annotation of
the TSS or failure to detect representative FOXM1-MuvB,
MMB or DREAM components at promoters. Given the
small overlap of cell cycle-regulated genes in the screens
used for classification of peak expression, particularly these
assays seem to be prone to artifacts (Figure 2A). Moreover,
when we searched for CHR elements with two deviations
from TTTGAA, we had to include the CDE as an anchor
sequence to reduce the number of hits for experimental val-
idation. This dramatically reduced the number of candidate
CHR elements in the search and hence may have led us to
ignore CHRs unlinked to a CDE. Nevertheless, we think
that we missed only a small number of sites. We reason that
most potential CHR elements that differ in more than one
nucleotide from the canonical sites are most likely not func-
tional, because already most elements with single nucleotide
exchanges are clearly underrepresented in comparison to
the canonical elements. Also, the three sites that deviate in
two nucleotides from TTTGAA can only be found in four
promoters.
Furthermore, we have identified CHR-like sequences in
the human and mouse NEK2 promoters and in the mouse
Exo1 promoter that show clear features of CHR elements
since mutation disrupts cell cycle-dependent transcription
and results in a strong elevation of promoter activity al-
ready in G0. Even though DREAM binding to these pro-
moters is observed in ChIP assays, we could not detect an
interaction of DREAM with the potential CHRs in DNA
affinity purifications. However, since the DNA probes used
for these experiments were amplified on basis of the cloned
promoters that contain all evolutionary conserved elements
around the TSS and show proper regulation during the cell
cycle (Supplementary Figures S2 and S3), it seems unlikely
that DREAM binds to elements that are located outside the
tested promoter region. It is more likely that DREAM has
a low affinity to the CHR-like elements in vitro that pre-
vents detection of the interaction. Also, we have screened
the D+LCC data set for these elements and did not find ad-
ditional candidates for testing. Therefore, we can rule out
that there is a large group of genes regulated through these
elements. Taken together, it appears that the three most
common CHR sequences are present in 80% of all CHR
promoters: TTTGAA, TTTAAA and TTCGAA (Figures 6
and 8). Interestingly, DREAM bound with the highest affin-
ity to DNA probes carrying these sites (Figure 1B). The re-
maining seven elements account for only 20% of all CHRs
and also bind DREAM with a lower affinity in vitro. Since
we found at least one of the 10 CHR sequences in 95% of
late cell cycle genes bound by DREAM and MMB as well as
by FOXM1, it is likely that we identified most of the CHR
sequences associated with late cell cycle genes.
Forty five percent of the identified CHR elements had a
reverse orientation to the TSS, which is in agreement with
the finding that CHRs can be functional in both orienta-
tions (2). Interestingly, when found close to the transcrip-
tion start sites of head-to-head orientated genes, the CHR
elements did not mediate co-expression of these genes. This
was not expected since bidirectional genes sharing one pro-
moter region are often functionally related, co-regulated
and co-expressed (61). In all observed cases, only one of the
head-to-head-orientated genes was identified as a late cell
cycle gene although the CHRs were located in a window of
200 bp around the TSS of both genes (Supplementary Fig-
ure S5). As we generally find other regulatory elements like
CCAAT-boxes to be located upstream of the CHRs (1), it
is more likely that the specific localization of all elements
determines the direction of transcription. Additionally, in-
sulator elements may contribute to the different expression
of these genes.
Analysis of other potential binding sites: E2F, CDE, MBS,
FBS
The exact mechanism of DREAM, MMB and FOXM1-
MuvB binding to promoter elements is still unclear. Five
components of the MuvB core or its associated proteins
are considered to be DNA-binding transcription factors:
E2F4, DP1, LIN54, B-MYB and FOXM1. LIN54 is the
only component that is part of both the repressing as well as
the activating complexes and was found to be able to bind
the CHR in the Cdk1 promoter in vitro (3). Recently, we
have shown that DREAM, MMB and also FOXM1-MuvB
can bind DNA through CHR sites (2,6,62). Consistently,
the computational approach in our current study identified
CHRs in 95% of late cell cycle genes bound by DREAM
and MMB as well as FOXM1 which clearly indicates that
CHR sites are required for the regulation of late cell cycle
genes by these proteins. Moreover, we observed that 27% of
DREAM-bound genes contain conserved E2F sites in their
proximal promoters. It had been shown that DREAM can
bind to promoters with E2F sites, while MMB and FOXM1
do not (4,6,8). Even though the interaction of DREAM
with E2F binding sites has not been studied in detail, the
available data suggest that DREAM, in addition to con-
tacting the CHR and regulating G2/M genes without the
requirement of E2F sites, also binds and represses early cell
cycle genes through an interaction of E2F4/DP1 with E2F-
binding sites. Thus, both types of DNA sites may comple-
ment each other in mediating repression of early and late
cell cycle genes by DREAM. Interestingly, we identified a
large group of genes with promoters bound by DREAM
that harbor evolutionary conserved CHRs as well as E2F
sites (Figure 6A). More than 80% of these promoters show
peak expression in late cell cycle phases like promoters that
solely harbor CHRs (Figure 7A). We also analyzed whether
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Figure 9. Regulation of late cell cycle genes through sequential binding of DREAM, MMB and FOXM1-MuvB to the CHR. In the derived model, all
complexes are recruited to CHR elements via MuvB. Expression of late cell cycle genes is repressed in G0 and G1 by DREAM. CDE elements can support
binding of DREAM to the CHR. In early S phase, MMB binds to the CHR. Later, MMB recruits FOXM1, which results in initiation of transcription. In
G2 and M phases, B-MYB is degraded and expression of late cell cycle genes reaches its maximum through activation by FOXM1-MuvB.
E2F/CHR promoters are activated significantly earlier in
the cell cycle than CHR promoters, but did not observe ob-
vious timing differences based on currently available data.
The timing of gene expression during the cell cycle thus ap-
pears to be regulated through CHR elements in cases where
both elements are located in the same promoter. However,
as these E2F sites are phylogenetically conserved, it is highly
likely that they also have a functional significance, for exam-
ple for reaching the full promoter activity by binding acti-
vating E2F proteins.
Initial reports had identified CDE sites four nucleotides
upstream from CHRs and suggested that in most genes a
combination of CDE and CHR elements is necessary for
cell cycle-dependent regulation (1). In contrast to this no-
tion, we found the CHR elements but not CDEs to be highly
conserved (Figure 8D). Moreover, in the group of CHR-
containing promoters bound by DREAM and expressed
late during the cell cycle only 23% contained a CDE (Sup-
plementary Table S3). These findings are consistent with
our observation that CDEs support binding of DREAM
to CHR elements and increase the regulation of promoters,
but CDE sites are not essential for function (2). DREAM
can bind to CHR elements without support of a CDE (2).
Additionally, MMB and FOXM1-MuvB do not interact
with CDE elements (2,6,62). These observations lead us to
conclude that evolutionary pressure on CHR elements is
much higher than on CDEs. This also explains that CHR
sites, in contrast to CDEs, are highly conserved.
In contrast, a general role of MBS and FBS in recruiting
the MMB- and MuvB–FOXM1 complexes is unlikely. We
did not find an enrichment of evolutionary conserved MBS
elements in promoters without a CHR bound by MMB
or FOXM1. Moreover, in promoters bound by DREAM,
MMB and FOXM1, such elements are completely ab-
sent. However, 17% of the genes bound by all three com-
plexes contain evolutionary conserved MBS co-occurring
with CHR elements. In contrast, CHRs without MBS are
found in 65% of such promoters (Figure 6B). ChIP experi-
ments with transiently transfected promoter constructs sug-
gested that MMB is recruited to the Birc5/survivin promoter
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through four non-conserved MBS elements (9). In another
report from the same group, it was shown that binding of
FOXM1 to the survivin promoter depends also on the four
MBS (7). However, a canonical CHR site in the survivin pro-
moter located close to the TSS was not investigated in both
reports, although it had been reported to be regulating this
promoter (44). We analyzed the CHR and MBS elements in
the survivin promoter and found that the promoter is largely
deregulated upon mutation of the CHR, while its activity re-
mained essentially unchanged after mutation of the MBS el-
ements in all phases of the cell cycle (Supplementary Figure
S4). Thus, the results provide strong evidence that the CHR
is the main element necessary for cell cycle-dependent tran-
scriptional regulation also of the survivin promoter. Fur-
thermore, since only 3% of all cell cycle promoters bound by
MMB contain MBS elements without also carrying CHRs,
it is unlikely that recruiting MMB through MBS elements
to promoters of late cell cycle genes without participation
of CHRs is a common mechanism. This model is in agree-
ment with the observation that loss of Myb in Drosophila
leads to reduced expression of late cell cycle genes and adult
lethality, but these defects do not depend on the ability of
Myb to bind to DNA since DNA-binding-deficient Myb
mutants can rescue the Myb-null mutants (63). Addition-
ally, MMB is still targeted to essential late cell cycle genes
even in the absence of Myb, and Myb only contributes to
targeting of MMB to a subset of non-cell-cycle-regulated
genes (64). However, since we found evolutionary conserved
MBS in 17% of CHR promoters binding DREAM, MMB
and FOXM1, it may be possible that MBS are involved in
the regulation of a subgroup of mammalian CHR promot-
ers. An interaction of B-MYB with MBS may support bind-
ing of MMB to CHRs, similar to CDE elements supporting
binding of DREAM to CHR sites. In contrast to CDE sites,
the distance between the identified MBS and CHRs is not
conserved. Thus, a possible participation of such elements
co-occurring with CHRs in the regulation of late cell cycle
genes and mechanistic details need to be investigated.
We also explored the possible involvement of FBS ele-
ments in binding FOXM1 in late cell cycle promoters. We
had shown before that CHRs are highly enriched in a set
of FOXM1-bound promoters using two motif finding tools,
but FBS elements did not accumulate (6). In contrast, Sada-
sivam et al. observed in addition to CHRs also an enrich-
ment of MBS and FBS elements in a set of MMB-bound
promoters utilizing de novo motif discovery tools (8). In or-
der to support one of the two binding models, we searched
for conserved FBS elements in the data sets of MMB- or
FOXM1-bound promoters. FBS elements were identified in
8% of promoters bound by FOXM1 and in only 4% of the
promoters bound by MMB compared to 13% in All Genes.
In the set of promoters bound by DREAM, MMB and
FOXM1, the fraction of promoters displaying only FBS el-
ements decreased to 2%, whereas CHR promoters accumu-
lated to 67%. In this data set, 15% of promoters contain
CHRs as well as FBS elements (Figure 6C). These results
are clearly inconsistent with an enrichment of FBS elements
in MMB- or FOXM1-bound cell cycle genes. Instead it fa-
vors a mechanism in which FOXM1 is recruited to CHRs
via MMB (6). This model is further supported by the find-
ing that FOXM1 in general has a very low affinity to FBS
elements (65).
In general, it has been observed that mutation of CHR el-
ements results in an activation of all promoters in G0 and G1
phases when tested in reporter assays which clearly shows
that CHRs are the central repressive elements in the pro-
moters of late cell cycle genes. The importance of the CHR
for activation is not as clear-cut. For the cyclin B2 pro-
moter, we have shown the DREAM, MMB and FOXM1
bind through the CHR and that mutation of the element re-
sults not only in an increased promoter activity in G0/G1,
but also in a decreased activity in G2/M (2,6,62). Further-
more, knockdown of B-MYB leads to a reduced activity of
the wild-type promoter, but not of the CHR mutant (2).
Thus, the CHR mediates repression as well as activation of
the cyclin B2 gene, most likely through an interaction with
Lin54 (3). In contrast, the activity of promoters like Chek2,
Melk and Pold1 was lower than the respective CHR mutants
in all phases of the cell cycle (Figure 4). In addition, only for
a subgroup of CHR promoters bound by DREAM an addi-
tional binding of MMB and FOXM1 (4,6,8) (Table 1) and a
reduced expression after knockdown of MMB components
(9,66) was reported. Thus, it remains open if activation by
MMB and FOXM1-MuvB is a general feature of all CHR
genes. However, in 95% of late cell cycle genes bound by
DREAM and MMB as well as by FOXM1, we have identi-
fied evolutionary conserved CHR elements, which supports
a general mechanism for this group of genes: If late cell cy-
cle genes are regulated by sequential binding of DREAM,
MMB and FOXM1-MuvB, then interaction of the com-
plexes with the promoters is mediated through CHR ele-
ments (Figure 9).
Binding of DREAM to non-cell cycle genes
In ChIP-chip analyses, DREAM binds also to non-cell
cycle-regulated genes (4). It is not clear whether these bind-
ing events contribute to transcription or if they represent
just non-functional protein–DNA interactions. Moreover,
bound transcription factors may become functional only in
certain tissues or after triggering by specific stimuli. Inter-
estingly, it was shown for the DREAM component E2F4
that protein binding to promoters is highly conserved be-
tween tissues of one species, while only 20% of bound genes
overlap between human and mouse (67). Consistent with
our observations, in the group of promoters bound in both
species, genes with functions in cell cycle regulation and
proliferation were highly overrepresented (67). Important
functions of DREAM in cell cycle regulation are there-
fore conserved between species and tissues, while other in-
teractions of DREAM with DNA may contribute to un-
known species-specific regulation or, more likely, may be
non-functional in most cases. This hypothesis is supported
by the finding that only 25% of genes bound by MMB in
their promoters vary in their expression after depletion of
MMB by siRNA in Drosophila (64). In agreement with the
concept that functional binding of transcription factors to
their binding elements is often evolutionary conserved, we
find CHR elements identified in human to be functional in
mouse as well (Figures 3–5). Even in cases in which we ob-
served differences in CHR nucleotide sequences of ortholog
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human and mouse genes, these variations did not impair
function as shown for the CHRs in the mouse and human
Pold1 promoters (Figures 3 and 4), (59).
In contrast to the group of genes only bound by
DREAM, we found a massive enrichment of cell cycle genes
in the group additionally bound by MMB or FOXM1. We
identified only three genes holding an evolutionary con-
served CHR and being bound by DREAM and MMB or
FOXM1 that were not cell cycle-regulated in our analy-
sis: HNRNPH2, LSM5 and RBMX. It remains to be clar-
ified if binding of the complexes to these non-cell cycle
genes has a physiological significance. In a recent publica-
tion, DREAM was implicated in the repression of genes
during osteoblast differentiation (68). In undifferentiated
proliferating MC3T3-E1 cells, DREAM was reported to
bind to Bglap and Alpl promoters and to repress these
osteoblast-specific genes. Since both promoters lack CHRs
or E2F sites, we were interested in elucidating the binding
of DREAM to these genes. However, we could not detect
binding of DREAM to Bglap or Alpl, neither in ChIP as-
says nor in DNA affinity purifications using preparations
of undifferentiated MC3T3-E1 cells, even when comparing
the Bglap and Alpl results to many positive controls proving
that the assays were able to detect DREAM binding to cell
cycle promoters (data not shown). As our data stand in con-
trast to the findings by Flowers et al., it appears question-
able if mammalian DREAM, like the ortholog complexes
in Drosophila and C. elegans, also participates in regulation
of differentiation in mammals (20,69,70).
In summary, we define CHR motifs and provide a com-
prehensive overview of CHR elements with their distribu-
tion in the human genome. We have identified evolutionary
conserved CHR elements in 95% of late cell cycle promot-
ers bound by DREAM and MMB as well as FOXM1. Such
genes are generally differentially expressed during the cell
cycle with a maximum in G2 and M phases. We conclude
that the CHR is the central promoter element in the tran-
scriptional regulation of late cell cycle genes by DREAM,
MMB and FOXM1-MuvB (Figure 9).
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14. Wasner,M., Tschöp,K., Spiesbach,K., Haugwitz,U., Johne,C.,
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